Overview

Effect of Opicapone at Steady State on Warfarin Pharmacokinetics

Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
Single-centre, open-label, fixed-sequence design consisting of 2 periods separated by a washout period of at least 14 days.
Phase:
Phase 1
Details
Lead Sponsor:
Bial - Portela C S.A.
Treatments:
Opicapone
Warfarin